Fundraising Fox
🦊/People
Sign in

Tay Salimullah

Investor

Venture Partner at 4BIO Capital

Greater Chicago Area

Find your path to Tay

286 people in our graph share verified history with Tay — schools, employers, funds. One of them is your warm intro.

Michael TaylorunlockedTay: together at Pfizer (2000–2007)
×3Tay: together at Pfizer
×4Tay: together at USAID
×3Tay: together at Brunel University of London

About

Tay Salimullah is the Founder and Managing General Partner at Renovamen Advisors LLC, where he works with founders, boards, and investors on company building, commercialization, governance, and investment for early-stage biotechs. Previously a member of the Novartis Gene Therapies executive team, he contributed to the development of Zolgensma into a global gene therapy franchise approved in more than 50 countries. He also serves as Venture Partner at 4BIO Capital, Chief Strategy Officer and Board Member at Trogenix, Board Advisor to iECURE, and Executive-in-Residence at the Alliance for Regenerative Medicine.

Experience

  1. Renovamen Advisors LLCFounder, Managing General Partnercurrent2024 — presentChicago, Illinois, United States
  2. TrogenixBoard Member & Chief Strategy Officercurrent2024 — present
  3. iECURE, inc.Board Commercial Advisorcurrent2025 — present
  4. 4BIO CapitalVenture Partnercurrent2024 — presentChicago, USA, London
  5. Alliance for Regenerative MedicineExecutive in Residencecurrent2024 — present
  6. Novartis Gene TherapiesCCO (formerly AveXis)2020 — 2024Greater Chicago Area
  7. Novartis Global HealthHead Global Business Franchise, Group Global Health2018 — 2020Basel Area, Switzerland
  8. NovartisGlobal Strategic Projects Leader, Worldwide Real World Evidence2017 — 2018Basel Area, Switzerland
  9. NovartisEx.Director US & Global Pricing & Market Access Cell & Gene Therapies2015 — 2017Basel Area, Switzerland
  10. Novartis OncologyGlobal Head Hematology RWE Program2015 — 2017Basel Area, Switzerland
  11. NovartisRegion Europe Market Access & Pricing Director2013 — 2015Basel Area, Switzerland
  12. Ascendancy HealthcareMarket Access Consultant - Singapore2012 — 2013Singapore
  13. Clermont GroupAssistant Vice President - Singapore2011 — 2012Singapore
  14. PfizerHealthcare Strategy Lead - Oncology Franchise2009 — 2011United Kingdom
  15. PfizerHead Strategic Market Access Payors2008 — 2009Europe
  16. PfizerPayor Strategy Leader - Strategic Market Access2007 — 2008London Area, United Kingdom
  17. PfizerCommercial Director - Oncology Franchise2005 — 2007United Kingdom
  18. PfizerHospital Sales Manager2002 — 2005London Area, United Kingdom
  19. USAIDStrategic Planning Consultant - AFRICA2009Malawi
  20. PfizerPrimary Care Sales Executive2000 — 2001London, United Kingdom

Skills & more

Market Access45Pharmaceutical Industry37Oncology29Business Strategy13Strategy7International Development4Big Data1Leadership8Cross-functional Team Leadership4Cell & Gene Therapies1

Languages English · Hindi · Punjabi · Urdu

  • Venture Capital and Private Equity: Investment Strategies — Imperial College London
  • Venture Capital and Private Equity: Investment Strategies — Imperial Business School
  • Venture Capital and Private Equity: Investment Strategies — Imperial Business School

From Tay's professional profile.

Colleagues at 4BIO Capital

Alexander Mckenna
Investment Associate at 4BIO Capital
Andrew Kozlov
Managing Partner at 4BIO Capital
Brian McVeigh
Venture Partner, USA at 4BIO Capital
Dima Kuzmin
Managing Partner at 4BIO Capital
Edward McGill
Financial Controller at 4BIO Capital
Eleanor Whate
Office Manager and Compliance Assistant at 4BIO Capital
Jack Shea-Firth
Investment Analyst at 4BIO Capital
Kieran Mudryy
Partner at 4BIO Capital

Frequently asked questions

Who is Tay Salimullah?
Tay Salimullah is the Founder and Managing General Partner at Renovamen Advisors LLC, where he works with founders, boards, and investors on company building, commercialization, governance, and investment for early-stage biotechs. Previously a member of the Novartis Gene Therapies executive team, he contributed to the development of Zolgensma into a global gene therapy franchise approved in more than 50 countries. He also serves as Venture Partner at 4BIO Capital, Chief Strategy Officer and Board Member at Trogenix, Board Advisor to iECURE, and Executive-in-Residence at the Alliance for Regenerative Medicine.
Where does Tay Salimullah work?
Tay Salimullah is Venture Partner at 4BIO Capital.
Where did Tay Salimullah go to school?
Tay Salimullah studied at Imperial College London (Executive Education, Venture Capital and Private Equity); Boston University School of Public Health (Pfizer Global Health Fellowship (Class 10), International Public Health); Brunel University of London (BSc Business Management Studies).

Same school

Shared employers